Ultimate Products (ULTP) H1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 TU earnings summary
11 Feb, 2026Executive summary
Proprietary brand sales increased by 5% year-over-year to £65.8m, aligning with the strategic focus on owned brands.
Total group revenue declined 6% year-over-year to £74.5m, reflecting subdued consumer demand and a planned reduction in non-core third-party clearance sales.
Trading performance remains in line with market expectations despite challenging market conditions.
Financial highlights
Adjusted EBITDA for H1 2026 is expected to be around £5.0m, impacted by lower sales.
Net bank debt at period end was £9.7m, down from £14.1m at 31 July 2025.
Net bank debt/adjusted EBITDA ratio improved to 0.9x from 1.1x at 31 July 2025.
Rolling 12-month average net bank debt/adjusted EBITDA was 1.4x.
Outlook and guidance
Current trading is in line with market expectations.
Board remains confident that ongoing investment in operational capabilities will position the group for growth as macroeconomic conditions improve.
FY26 consensus revenue is £137.7m, with adjusted EBITDA of £12.5m and adjusted EPS of 7.4p.
Latest events from Ultimate Products
- Revenue down 6%, but proprietary brands grew 5% and international branded sales rose 19%.ULTP
H1 202624 Mar 2026 - Revenue and profit declined, but European growth and stable margins support a positive outlook.ULTP
H2 202426 Feb 2026 - Revenue and profit fell, but branded and international sales and operational changes drive future growth.ULTP
H2 202522 Dec 2025 - Flat full-year revenue and EBITDA of £14–16m expected, with international growth offsetting UK weakness.ULTP
Trading Update1 Dec 2025 - FY25 revenue and profit guidance lowered as sales shift to lower margin categories and orders defer.ULTP
Trading Update30 Jun 2025 - Revenue and profit fell in FY24, but FY25 starts strong with cautious optimism.ULTP
Trading Update13 Jun 2025 - H1 revenue down 6% with UK weakness offset by European growth; margin recovery expected in H2.ULTP
H1 20255 Jun 2025